Jeffrey S. Hatfield

CIK 1609879 · Chief Executive Officer · last filed 2026-05-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$342.7K

Companies

8

Total Filings

33

Lifetime Open-Market Net

-$1.42M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VIR Director 39,806 $8.61 $342.7K $0 7 2026-05-28
VRDN Director $16.35 $0 1 2021-02-08
Viridian Therapeutics, Inc.\DE (MGEN) Delisted Director $0 3 2020-05-22
LIFE Director $15.61 $0 5 2020-05-08
Larimar Therapeutics, Inc. (ZFGN) Delisted Chief Executive Officer $0 4 2019-01-24
INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted Director $0.32 $0 2 2018-01-23
Vitae Pharmaceuticals, Inc (VTAE) Delisted Chief Executive Officer 244,996 -$1.42M 10 2016-10-25
AMBIT BIOSCIENCES CORP (AMBI) Delisted Director $0.54 $0 1 2014-11-12

Recent Filings · Page 4 of 4

33 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-02-18 Vitae Pharmaceuticals, Inc (VTAE) Delisted Grant (A) $0 EDGAR
2015-01-26 Vitae Pharmaceuticals, Inc (VTAE) Delisted Exer (M) +39,097 $45.0K EDGAR
2014-11-12 AMBIT BIOSCIENCES CORP (AMBI) Delisted Disp (D) $0 EDGAR
Showing 3133 of 33
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.